• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Gastrointestinal symptoms in COVID-19.新型冠状病毒肺炎的胃肠道症状
Prz Gastroenterol. 2023;18(1):61-66. doi: 10.5114/pg.2021.112683. Epub 2022 Jan 18.
2
Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19.新冠病毒胃肠道感染的发病机制与作用机制。
Front Immunol. 2021 Nov 10;12:674074. doi: 10.3389/fimmu.2021.674074. eCollection 2021.
3
Autoimmunity and COVID-19 - The microbiotal connection.自身免疫与 COVID-19:微生物组的关联。
Autoimmun Rev. 2021 Aug;20(8):102865. doi: 10.1016/j.autrev.2021.102865. Epub 2021 Jun 10.
4
Gastrointestinal Involvement in SARS-CoV-2 Infection.新型冠状病毒感染的胃肠道表现。
Viruses. 2022 May 30;14(6):1188. doi: 10.3390/v14061188.
5
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
6
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.2019 年冠状病毒病中肠道微生物组的改变及其治疗潜力。
World J Gastroenterol. 2022 Dec 21;28(47):6689-6701. doi: 10.3748/wjg.v28.i47.6689.
7
COVID-19 - gastrointestinal and gut microbiota-related aspects.COVID-19 - 与胃肠道和肠道微生物群相关的方面。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10853-10859. doi: 10.26355/eurrev_202010_23448.
8
SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与免疫微生物组相互作用:呼吸道病毒感染的经验教训
Int J Infect Dis. 2021 Apr;105:540-550. doi: 10.1016/j.ijid.2021.02.071. Epub 2021 Feb 18.
9
Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.评估与 SARS-CoV-2 感染相关的肠道和上呼吸道中的微生物群。
Microbiome. 2023 Mar 3;11(1):38. doi: 10.1186/s40168-022-01447-0.
10
Roles of the gut microbiota in severe SARS-CoV-2 infection.肠道微生物群在严重 SARS-CoV-2 感染中的作用。
Cytokine Growth Factor Rev. 2022 Feb;63:98-107. doi: 10.1016/j.cytogfr.2022.01.007. Epub 2022 Jan 31.

引用本文的文献

1
Can Novel Biomarkers Effectively Predict Acute Kidney Injury in Liver or Kidney Transplant Recipients?新型生物标志物能否有效预测肝或肾移植受者的急性肾损伤?
Int J Mol Sci. 2024 Nov 10;25(22):12072. doi: 10.3390/ijms252212072.
2
A forecasting method of postoperative intestinal paralysis and its timely resolution.一种术后肠麻痹的预测方法及其及时解决措施。
Prz Gastroenterol. 2023;18(4):393-401. doi: 10.5114/pg.2023.133063. Epub 2023 Nov 22.
3
Impact of Symptomatology, Clinical and Radiological Severity of COVID-19 on Pulmonary Function Test Results and Functional Capacity during Follow-Up among Survivors.COVID-19的症状学、临床及影像学严重程度对幸存者随访期间肺功能测试结果及功能能力的影响
J Clin Med. 2023 Dec 21;13(1):45. doi: 10.3390/jcm13010045.
4
Long-lasting dyspeptic symptoms - another consequence of the COVID-19 pandemic?长期消化不良症状——新冠疫情的又一后果?
Prz Gastroenterol. 2023;18(2):175-182. doi: 10.5114/pg.2023.129414. Epub 2023 Jul 27.
5
BBIBP-CorV Vaccination against the SARS-CoV-2 Virus Affects the Gut Microbiome.接种BBIBP-CorV新冠疫苗会影响肠道微生物群。
Vaccines (Basel). 2023 May 4;11(5):942. doi: 10.3390/vaccines11050942.

本文引用的文献

1
Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.SARS-CoV-2 刺突蛋白诱导的小鼠模型细胞因子特征。
Front Immunol. 2021 Jan 28;11:621441. doi: 10.3389/fimmu.2020.621441. eCollection 2020.
2
Human recombinant soluble ACE2 in severe COVID-19.严重新型冠状病毒肺炎中的人重组可溶性血管紧张素转换酶2
Lancet Respir Med. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.
3
How COVID-19 induces cytokine storm with high mortality.新冠病毒如何引发高死亡率的细胞因子风暴。
Inflamm Regen. 2020 Oct 1;40:37. doi: 10.1186/s41232-020-00146-3. eCollection 2020.
4
Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019.新冠肺炎住院患者的消化系统表现。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1355-1365.e4. doi: 10.1016/j.cgh.2020.09.041. Epub 2020 Oct 1.
5
Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis.COVID-19 患者伴胃肠道症状的患病率和死亡率:一项系统评价和荟萃分析。
Mayo Clin Proc. 2020 Aug;95(8):1632-1648. doi: 10.1016/j.mayocp.2020.06.003. Epub 2020 Jun 10.
6
Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.2019 年冠状病毒病患者的胃肠道症状和粪便病毒脱落的流行情况:系统评价和荟萃分析。
JAMA Netw Open. 2020 Jun 1;3(6):e2011335. doi: 10.1001/jamanetworkopen.2020.11335.
7
AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.美国胃肠病学会关于新型冠状病毒肺炎胃肠道和肝脏表现的快速综述、国际数据的荟萃分析以及新型冠状病毒肺炎患者咨询管理建议
Gastroenterology. 2020 Jul;159(1):320-334.e27. doi: 10.1053/j.gastro.2020.05.001. Epub 2020 May 11.
8
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎患者胃肠道及肝脏受累的表现和预后:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-678. doi: 10.1016/S2468-1253(20)30126-6. Epub 2020 May 12.
9
Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications.纽约大量新冠病毒感染患者的2019冠状病毒病的胃肠道和肝脏表现:临床意义
Gastroenterology. 2020 Sep;159(3):1137-1140.e2. doi: 10.1053/j.gastro.2020.05.010. Epub 2020 May 8.
10
Addressing multiple gastroenterological aspects of coronavirus disease 2019.探讨 2019 冠状病毒病的多个肠胃病学方面。
Pol Arch Intern Med. 2020 May 29;130(5):420-430. doi: 10.20452/pamw.15332. Epub 2020 May 1.

新型冠状病毒肺炎的胃肠道症状

Gastrointestinal symptoms in COVID-19.

作者信息

Lewandowski Konrad, Kaniewska Magdalena, Rosołowski Mariusz, Rydzewska Grażyna

机构信息

Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Unit, Central Clinical Hospital of Ministry of Inferior and Administration, Warsaw, Poland.

Department of Internal Medicine and Hypertension, Medical University of Bialystok, Bialystok, Poland.

出版信息

Prz Gastroenterol. 2023;18(1):61-66. doi: 10.5114/pg.2021.112683. Epub 2022 Jan 18.

DOI:10.5114/pg.2021.112683
PMID:37007763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10050985/
Abstract

SARS-CoV-2 infection manifests mainly by involving the respiratory system. Due to the presence of abdominal symptoms, the digestive system is clearly involved in the expression, transmission, and possible pathogenesis of COVID-19. There are many theories regarding the development of abdominal symptoms, including angiotensin 2 receptor, cytokine storm, and disturbances of the intestinal microbiome. This paper provides an overview of the most important meta-analyses and publications on gastrointestinal symptoms and the gut microbiome in COVID-19.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染主要表现为累及呼吸系统。由于存在腹部症状,消化系统显然参与了冠状病毒病(COVID-19)的表现、传播及可能的发病机制。关于腹部症状的发生发展有许多理论,包括血管紧张素2受体、细胞因子风暴和肠道微生物群紊乱。本文概述了关于COVID-19胃肠道症状和肠道微生物群的最重要的荟萃分析及出版物。